Faculty

Alison Drake

Adjunct Associate Professor, Epidemiology
Associate Professor, Global Health

206-543-5847

Education

PhD Epidemiology, University of Washington, 2010
MPH Epidemiology, University of Michigan, 2002
BS Microbiology, University of Michigan, 2000

Contact

206-543-5847

University of Washington Department of Global Health 3980 15th Ave NE Rm 884
Box 351620
Seattle, WA 98195

Bio

Alison Drake, MPH, PhD is an epidemiologist and Associate Professor at the University of Washington in the Department of Global Health. She is currently an Assistant Director of the Global Center for Integrated Health of Women, Adolescent, and Children (Global WACh) and co-Director of the Family Planning Decision Support Scientific Priority Area for Global WACh. Dr. Drake’s research interests include HIV prevention among women and adolescents, incident maternal HIV infections, vertical HIV transmission, adolescent reproductive health, mobile health, and family planning. She is the PI for an R01 testing a mobile health counseling intervention to reduce contraceptive discontinuation and help women living with HIV achieve their reproductive health goals in a randomized clinical trial in Kenya. She is also a co-PI of 2 studies on COVID-19 prevalence, household transmission, and antibody response among pregnant women and their household members in the Seattle area. In addition, she is a co-instructor for two courses in the School of Public Health, Responsible Conduct of Research: Global to Local and Global Perspectives on Reproductive Health.

Research Interests

  • HIV
  • Material & child health
  • Infections during pregnancy
  • Vertical HIV transmission
  • Family planning 
  • Reproductive health

Recent Publications (PubMed)

Hybrid immunity to SARS-CoV-2 during pregnancy provides more durable infant antibody responses compared to natural infection or vaccination alone.
(2024 Jan 29)
J Infect Dis
LaCourse SM, Wetzler EA, Aurelio MC, Escudero JN, Selke SS, Greninger AL, Goecker EA, Barnes SR, Arnould IS, Pérez-Osorio AC, Richardson BA, Kachikis A, Englund JA, Drake AL

Hybrid immunity to SARS-CoV-2 during pregnancy provides more durable infant antibody responses compared to natural infection alone.
(2023 Dec 21)
J Infect Dis
LaCourse SM, Wetzler EA, Aurelio MC, Escudero JN, Selke SS, Greninger AL, Goecker EA, Barnes SR, Arnould IS, Pérez-Osorio AC, Richardson BA, Kachikis A, Englund JA, Drake AL

HIV Viral Load Patterns and Risk Factors Among Women in Prevention of Mother-To-Child Transmission Programs to Inform Differentiated Service Delivery.
(2024 Mar 1)
J Acquir Immune Defic Syndr 95(3): 246-254
Jiang W, Ronen K, Osborn L, Drake AL, Unger JA, Matemo D, Richardson BA, Kinuthia J, John-Stewart G

Prevalence and Predictors of Chlamydia trachomatis and Neisseria gonorrhoeae Among HIV-Negative Pregnant Women in Kenya.
(2024 Jan 1)
Sex Transm Dis 51(1): 65-71
Mogaka JN, Drake AL, Matemo D, Kinuthia J, McClelland RS, Unger JA, Richardson BA, John-Stewart G, Pintye J

Severe acute respiratory syndrome coronavirus 2 seroprevalence and longitudinal antibody response following natural infection in pregnancy: A prospective cohort study.
(2023 Jan-Dec)
Womens Health (Lond) 19(): 17455057231190955
Drake AL, Escudero JN, Aurelio MC, Wetzler EA, Ellington SR, Zapata LB, Galang RR, Snead MC, Yamamoto K, Salerno CC, Richardson BA, Greninger AL, Kachikis AB, Englund JA, LaCourse SM

Show complete publication list